listing

HTX Outperforms Industry Peers at the Start of 2026, Leveraging Disciplined Listing Strategies to Capture “Smart Money” Inflows

PANAMA CITY, Feb. 11, 2026 /PRNewswire/ -- In 2025, amid heightened volatility and widening dispersion across sectors, HTX delivered a…

3 days ago

NYSE Content Update: Boyd Group Services Rings Opening Bell to Celebrate Recent Listing

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 10, 2026 /PRNewswire/ -- The New York…

4 days ago

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix,…

1 week ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE)…

1 week ago

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 02, 2026 16:05 ET  | Source: Candel Therapeutics NEEDHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc.…

2 weeks ago

CORRECTING and REPLACING — BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

January 27, 2026 17:10 ET  | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- In…

3 weeks ago

Nexalin Technology Receives Nasdaq Listing Status Notification

HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in…

3 weeks ago

HTX’s 2025 Listing Strategy Review, Building a High-Liquidity Ecosystem Through First-Mover Advantage and Longtermism

PANAMA CITY, Jan. 23, 2026 /PRNewswire/ -- In 2025, persistent macro uncertainty and rapidly shifting crypto narratives turned asset selection…

3 weeks ago

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: Context Therapeutics Inc. PHILADELPHIA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc.…

4 weeks ago

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”…

4 weeks ago